Further Reading

Opportunities and priorities for breast surgical research, November 2018

The 2013 Breast Cancer Campaign gap analysis established breast cancer research priorities without a specific focus on surgical research or the role of surgeons on breast cancer research. This Review aims to identify opportunities and priorities for research in breast surgery to complement the 2013 gap analysis. To identify these goals, research-active breast surgeons met and identified areas for breast surgery research that mapped to the patient pathway. Areas included diagnosis, neoadjuvant treatment, surgery, adjuvant therapy, and attention to special groups (eg, those receiving risk-reducing surgery). Section leads were identified based on research interests, with invited input from experts in specific areas, supported by consultation with members of the Association of Breast Surgery and Independent Cancer Patients' Voice groups. Surgeons are ideally placed for a central role in breast cancer research and should foster a culture of engagement and participation in research to benefit patients and health-care systems. Development of infrastructure and surgical research capacity, together with appropriate allocation of research funding, is needed to successfully address the key clinical and translational research gaps that are highlighted in this Review within the next two decades.



Prof Ramsey I Cutress, et al. Lancet, Vol 19, Issue 10, PE521-E533, Oct, 2018

DOI: https://doi.org/10.1016/S1470-2045(18)30511-4


See below for report

surgical-gap-analysis-v18-abs-002 (1).do[...]
Microsoft Word document [70.9 KB]

Research Involvement and Engagement

Research Involvement and Engagement is an interdisciplinary, health and social care journal focussing on patient and wider involvement and engagement in research, at all stages. The journal is co-produced by all key stakeholders, including patients, academics, policy makers and service users.


Breast Screening Review, October 2012

An independent panel has published the results of a review of the UK’s breast screening programmes.
The review was set up after concerns were raised that women were being told a lot about the benefits of screening and not enough about the possible harm.
With different experts speaking out both for and against breast screening, a public review was needed to help women understand the pros and cons of screening. The Government and Cancer Research UK asked a world-renowned epidemiologist, Professor Sir Michael Marmot, to chair an independent panel to review all the available evidence.
The panel’s aim was to reach an agreement on the balance of breast screening’s pros and cons. The decision for any individual woman is a personal one and not necessarily an easy one; we have tried to set out the evidence as clearly as we can, so that all women can make the decision that is right for them.

Maggie Wilcox was a member of this panel.


Adobe Acrobat document [241.8 KB]

Assessing Public Attitudes to Health Related Findings in Research 


During research involving human participants, researchers may find something that has direct significance for a participant’s health; for example, revealing an undiagnosed disease or an increased risk of illness. There is limited understanding of public attitudes towards these health related findings, and the Wellcome Trust and Medical Research Council commissioned research to address this evidence gap. 'Assessing Public Attitudes to Health Related Findings in Research' reports the findings of this research, which included qualitative extended focus groups and a large scale quantitative survey conducted by Opinion Leader in the UK in 2011/12.


The full report can be downloaded here - http://www.wellcome.ac.uk/About-us/Publications/Reports/Public-engagement/WTVM055197.htm


See below for a summary and Lay Comments on Incidental Findings

M W Lay comments on subject of Feedback[...]
Adobe Acrobat document [206.3 KB]

Impact of Patient, Carer and Public Involvement in Cancer Research

This report from NCRN and NCRI highlights the impact of patient, carer and public involvement (PPI) in cancer research. For researchers and clinicians it provides information about how patient and public involvement can contribute to studies and to clinical trials. For patients and carers considering involvement, it shows the diversity and value of the opportunities open to them at national, regional and local levels.



The power of information: putting all of us in control of the health and care information we need

This information strategy from the Department of Health sets a ten-year framework for transforming information for the NHS, public health and social care.



King's Fund

Many doctors aspire to excellence in diagnosing disease. Far fewer, unfortunately, aspire to the same standards of excellence in diagnosing patients’ preferences for their care. Because doctors are rarely made aware of an erroneous preference diagnosis, it could be called ‘the silent misdiagnosis’. Misdiagnosing patients’ preferences may be less obvious than misdiagnosing disease, but the consequences for the patient can be just as severe.

Patients’ preferences matter: stop the silent misdiagnosis outlines the scale of the problem. Full report can be downloaded at - http://www.kingsfund.org.uk/publications/patients_preferences.html



A new publication from INVOLVE provides guidance and advice to researchers on public involvement in clinical trials. 



Cancer Research UK

CRUK's recommendations to reform the clinical trials directive and other policy documents. http://info.cancerresearchuk.org/publicpolicy/workingwithgovernment/europe/


A patient survey in response to a government consultation on Value Based Pricing. In 2014 the Pharmaceutical Price Regulation Scheme, the current mechanism by which the NHS sets the price for all new drugs, will be replaced by a "value-based pricing" scheme. This will impact on the way in which treatments are assessed for use on the NHS. http://scienceblog.cancerresearchuk.org/wp-content/uploads/2011/12/CR-UK-Patients-Views-on-VBP.pdf


Listening is lynchpin of good patient care

Speaking to an audience of health professionals paying tribute to the work of the late Dr Ann McPherson, RCGP chair Dr Clare Gerada said excellent communication and listening skills are the values on which general practice and the wider NHS were built.

She commended Dr McPherson, a GP in Oxford, for fighting for what she believed in and for standing up and giving patients a voice – particularly through her work with the Healthtalkonline website which helps patients share their health concerns. Click here to read the full text of her talk. http://www.rcgp.org.uk/PDF/Ann%20McPherson%20presentation%20-%208%20May.pdf


Cochrane Reviews

Cochrane Reviews are systematic reviews of primary research in human health care and health policy, and are internationally recognised as the highest standard in evidence-based health care. They investigate the effects of interventions for prevention, treatment and rehabilitation. They also assess the accuracy of a diagnostic test for a given condition in a specific patient group and setting. They are published online in The Cochrane Library.


AllTrials logo


VOICE 2022

We are pleased to announce that the VOICE course will be residential and held at Barts Cancer Centre from 4-8 Sept. Click here for further details.


OPTIMA is a patient driven clinical study for people with hormone sensitive early breast cancer. 

OPTIMA aims to improve the way we make decisions about whom we offer chemotherapy to following surgery.
Check the website link for more information or listen to the short video to explain the trial.


Immunology Talk

On the 25th March we held an interactive talk and discussion on immunology.

The talk was given by Dr Edd James, Cancer Immunologist from the university of Southampton. The tallk is now available on YouTube - click here to listen. 


Long Term Survivor Study 

Continuum Life Sciences are looking for volunteers who have survived aggressive, difficult to treat cancer against all odds to take part in their Long-Term Survivor of Cancer Study. For more information and how you can join go to their website.


Save the planet and donate to ICPV - send ecards go tour Fundraising page for mor information.

FAST-Forward Trial Results

A one-week course of radiotherapy in fewer but larger daily doses was found to be as safe and effective as standard three-week therapy for women following surgery for early stage breast cancer. Trial results now published. Two ICPV members provided the PPI for this key trial. Full details can be found on the ICR Website.

ICPV Brighton Summer School Aug 2019

ICPV was once again hosted by SHORE-C at the University of Sussex. Click here for more info.

San Antonio Breast Cancer Symposium, 2018

ICPV member Pat Fairbrother attended this event on an Alamo Foundation Scholarship. Click here to read her review.

Gap Analysis in Breast Surgery Published

The 2013 Breast Cancer Campaign gap analysis established breast cancer research priorities without a specific focus on surgical research or the role of surgeons on breast cancer research. This Review aims to identify opportunities and priorities for research in breast surgery to complement the 2013 gap analysis. Click here for more information

ICPV Review 2018
We have at last published a new edition of our review. This was achieved by a grant from Novartis. Click here for more information. 

Award for ICPV Member

Many congratulations to ICPV member Margaret Grayson. On 21 April 2018 she received the Iris Colvin Lifetime Achievement Award for Health, presented by the Women’s Forum of Northern Ireland. This is very well deserved for her tireless work in furthering cancer research especially in Northern Ireland.

Contact us by email



Or use our online contact form